About Neuron23
Neuron23 is developing a precision medicine approach designed to improve the lives of people with Parkinson’s disease.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
South San Francisco, United States
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
neuron23.com
Domain Registered Date
Aug 8, 2018
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $97,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $100,000,000 · Series-B+
fundraisingfox.com
- Milestone
X account created (@official_N23)
132 followers
- Milestone
Website domain registered
neuron23.com
Investors & Backers
Acorn Bioventures
Blue Owl Capital
Cowen Healthcare Investments
HBM Healthcare Investments
HBM Partners
Kleiner Perkins
Michael J. Fox Foundation
Perceptive Advisors
Redmile Group
SoftBank Vision Fund
Surveyor Capital
Westlake Village BioPartners
Funding History
Series-B+
· Jun 24, 2025
$97,000,000 startupintros.com
Series-B+
· Mar 30, 2022
$100,000,000 fundraisingfox.com
Founders & Leadership
Adam Knight
Founder
Work email & phone locked
Unlock →
Andrew Yost
Chief Business Officer
Work email & phone locked
Unlock →
Marcel van der Brug
VP Genetics and Data Sciences
Work email & phone locked
Unlock →
Nancy Stagliano
Chief Executive Office
Work email & phone locked
Unlock →
Sam Jackson
Chief Medical Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026